Cas 392630-53-4,1-Piperidinecarboxamide, 4-[[4-[2-[[(2S)-3-(1,3-benzodioxol-5-yloxy)-2-hydroxypropyl]amino]ethyl] phenyl]sulfonyl]-N-octyl-

392630-53-4

Post Buying Request

Basic information

Product Name: 1-Piperidinecarboxamide, 4-[[4-[2-[[(2S)-3-(1,3-benzodioxol-5-yloxy)-2-hydroxypropyl]amino]ethyl] phenyl]sulfonyl]-N-octyl-
Synonyms:
CAS NO:392630-53-4
Molecular Formula: C32H47N3O7S
Molecular Weight: 617.807
EINECS: N/A
Product Categories: N/A
Mol File: 392630-53-4.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-Piperidinecarboxamide, 4-[[4-[2-[[(2S)-3-(1,3-benzodioxol-5-yloxy)-2-hydroxypropyl]amino]ethyl] phenyl]sulfonyl]-N-octyl-(CAS DataBase Reference)
NIST Chemistry Reference: 1-Piperidinecarboxamide, 4-[[4-[2-[[(2S)-3-(1,3-benzodioxol-5-yloxy)-2-hydroxypropyl]amino]ethyl] phenyl]sulfonyl]-N-octyl-(392630-53-4)
EPA Substance Registry System: 1-Piperidinecarboxamide, 4-[[4-[2-[[(2S)-3-(1,3-benzodioxol-5-yloxy)-2-hydroxypropyl]amino]ethyl] phenyl]sulfonyl]-N-octyl-(392630-53-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 392630-53-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

392630-53-4 Suppliers

Recommended suppliers

392630-53-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 392630-53-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,2,6,3 and 0 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 392630-53:
(8*3)+(7*9)+(6*2)+(5*6)+(4*3)+(3*0)+(2*5)+(1*3)=154
154 % 10 = 4
So 392630-53-4 is a valid CAS Registry Number.

392630-53-4Upstream product

392630-53-4Downstream Products

392630-53-4Relevant academic research and scientific papers

HETEROCYCLIC BETA-3 ADRENERGIC RECEPTOR AGONISTS

-

, (2008/06/13)

This invention provides compounds of Formula I having the structure U, V, W, X, and Y are as defined hereinbefore, or a pharmaceutically acceptable salt thereof, which are useful in treating or inhibiting metabolic disorders related to insulin resistance or hyperglycemia (typically associated with obesity or glucose intolerance), atherosclerosis, gastrointestinal disorders, neurogenetic inflammation, glaucoma, ocular hypertension and frequent urination; and are particularly useful in the treatment or inhibition of type II diabetes.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 392630-53-4